- ￥520
- 卡梅德/KMD Bioscience
- 天津
- KRP684
- 2026年01月26日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
- 英文名：
Recombinant Human M-CSF Protein
- 库存：
999
- 供应商：
卡梅德生物科技（天津）有限公司
- 规格：
20ug///50ug/// 100ug///200ug///1mg
| 产品编号 | KRP684 |
| 产品名称 | Recombinant Human M-CSF Protein |
| 别名 | 重组人M-CSF蛋白，Macrophage colony-stimulating factor 1, CSF-1, M-CSF, MCSF |
| 产品简介 | 重组人巨噬细胞集落刺激因子，是单核/巨噬细胞系发育与活化的必需因子。常用于巨噬细胞体外分化、免疫调节研究及肿瘤相关巨噬细胞模型构建。 |
| 分子名称 | CSF1 |
| 表达系统 | E.coli |
| 物种 | Human |
| 纯度 | >97%, determined by SDS-PAGE. |
| 应用 | WB, ELISA |
| 储存条件 | Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Avoid repeated freeze-thaw cycles. |
| 缓冲体系 | It is recommended that the lyophilized human M-CSF protein be dissolved in PBS at a concentration of 50-500 μg/mL for further dilution as the working concentration. |
| 产品背景 | 集落刺激因子的一种，是单核/巨噬细胞系发育、分化、存活和功能激活的关键调节因子，也参与破骨细胞生成和妊娠调节。 |
| 产品声明 | 该产品仅供科研使用，不可直接用于人体或注射。 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein
The cellular retinaldehyde-binding protein (CRALBP) is expressed at high levels in vertebrate visual trssue, where it may serve to modulate the interaction of 11-cis -retinol with visual-cycle enzymes in the retinal pigment epithelium (RPE
Recombinant Protein Production in Yeasts
Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging
Recombinant Protein Expression in Nicotiana
Recombinant protein pharmaceuticals are now widely used in treatment of chronic diseases, and several recombinant protein subunit vaccines are approved for human and veterinary use. With growing demand for complex protein pharmaceuticals
技术资料暂无技术资料 索取技术资料
